Myth Busters: Is What You Thought About Decentralized Clinical Trials Wrong?
In this webinar...
This webinar is associated with the DIA 2023 Global Annual Meeting and is open to the public. Stakeholders will discuss common myths about decentralized trials (DCTs).
As modern technologies are being advanced to support clinical trials, changes to how clinical trials are conducted are evolving. Change does require a careful evaluation of the regulatory environment and cultural differences, and this leads to assumptions and myths about whether and how DCT components may be implemented in clinical trials.
With total transparency, those are looming myths circulating in our industry, and instead of adding to this ever-growing myth list, this webinar will take a different approach to ‘debunk’ or confirm them. Industry leaders from competing vendors, sponsors, and sites will collaborate to share stories and findings of adoption, challenges, and evolving regulations related to the implementation of DCTs. Each participant will discuss specific myths and share evidence, and the audience will also be engaged to challenge the panel or share their own stories.
Who should attend?
Scientists, researchers, professionals working in clinical research, and academics.
Examples of assumptions and myths being discussed include:
- Use of mobile technology in the elder population
- Are DCTs all-or-nothing, or can patients be provided with options?
- China - what is permitted, and what are the restrictions?
- eConsent - where is it permitted; what is the difference between eConsent v. eSignature?
- Many others from the panel and audience
Learning Objectives:
- Discuss commonly heard assumptions about DCTs and provide evidence driven confirmation or refute the assumptions as a myth.